Director, Scientific Review Staff, OTBB, OND, CDER, FDA, United States
For the past 17 years while at the FDA, Dr. Ricci has made major contributions to guidance and standards development for biosimilars and other protein therapeutics. As Director of the Scientific Review Staff in the Office of Therapeutic Biologics and Biosimilars, Dr. Ricci leads a...
Read More →